reason report
merck acquisit bolster vaccin capabl pt
bottom line morn imdz announc enter
definit agreement acquir nr per share
approxim million all-cash transact repres
premium imdz close price yesterday increas
pt reflect acquisit agreement acquisit bolster
vaccin capabl add imdz proprietari technolog
glaa zvex imdz zvex platform prime immun system
vivo target dendrit cell lead optim antigen
present product cytotox lymphocyt imdz
second platform glaa boost immun respons
expand enhanc function recal imdz lead
program deriv glaa platform base
small molecul call glucopyranosyl lipid gla select
bind receptor evalu phase i/ii
follicular lymphoma studi local radiat alon combin
keytruda part clinic collabor view
unlik bidder emerg point transact
expect close earli agreement structur
all-cash tender offer acquir least major imdz outstand
share follow second-step merger remain imdz
share tender acquir
year price history/av daili volume mil imdz
compani inform svb leerink llc research
revenu million ep
pleas refer page import disclosur price chart analyst certif
imdz clinical-stag biotechnolog compani focus immuno-therapi cancer
compani experienc sever setback past focus develop effort
agonist imdz initi look develop combin keytruda
follicular lymphoma fl patient receiv prior line system therapi
believ compani focu advanc discontinu past program make sens
still uncertainti surround develop await clinic data
valid imdz develop strategi view execut import part imdz stori
price target imdz base blend dcf analysi revenu
multipl analysi assign valu probability-weight sale follicular lymphoma
potenti address indic repres upsid estim use
imdz pipelin program face clinic regulatori develop risk well
manufactur commerci intellectu properti risk imdz also face execut risk
financi risk also imdz may addit financ need turn cash flow posit
svb leerink estim compani file
chang
oper
invest
financ
svb leerink estim compani file
imdz pipelin upcom event
imdz world-wide right
clinic collabor
zvex rna
imdz world-wide right
imdz world-wide right
clinic collabor
agonist stabl emuls
